{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T12:16:15Z","timestamp":1788956175584,"version":"build-2803163510"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T00:00:00Z","timestamp":1748476800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T00:00:00Z","timestamp":1748476800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hereditas"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background and study aims<\/jats:title>\n                    <jats:p>To alleviate patient stress and advance gastric cancer research, this study aims to investigate the potential association between aberrant expression of TRG-AS1 and gastric cancer, and to examine its potential impact on the biological behaviors of gastric cancer cells.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>To find out how TRG-AS1 is expressed in the tissues and cells of gastric cancer, real-time fluorescence quantitative PCR was employed. The connection between TRG-AS1 and pathological features, as well as its prognostic importance, were examined using the Chi-square test and Cox regression analysis. The dual luciferase reporting assay was utilized to confirm the targeting of TRG-AS1 and miR-873-5p. Transwell assay and CCK-8 test were used to identify the roles that TRG-AS1 plays in cell metastasis and proliferation, respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Research has revealed a downregulation of TRG-AS1 in the tissues and cells, which is strongly correlated with the differentiation, TNM stage, lymph node metastasis, depth of invasion, and patient survival rate in gastric cancer. The binding sites exists between miR-873-5p and TRG-AS1, and TRG-AS1 has the ability to negatively control miR-873-5p by acting as a competitive endogenous RNA. When TRG-AS1 was overexpressed, the malignant behavioral activity of gastric cancer cells was significantly decreased; however, the inhibitory effect was reversed when miR-873-5p was overexpressed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>TRG-AS1 is a potential predictor of poor prognosis in gastric cancer patients and targets miR-873-5p to inhibit the progression of cancer.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s41065-025-00459-8","type":"journal-article","created":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T04:02:05Z","timestamp":1748491325000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Unraveling lncRNA TRG-AS1: a novel biomarker for poor prognosis of gastric cancer and key to regulating malignant behaviors by targeting miR-873-5p"],"prefix":"10.1186","volume":"162","author":[{"given":"Miao","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiesong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuzhen","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suping","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,29]]},"reference":[{"issue":"1","key":"459_CR1","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/s00432-022-04408-0","volume":"149","author":"C R\u00f6cken","year":"2023","unstructured":"R\u00f6cken C. Predictive biomarkers in gastric cancer. J Cancer Res Clin Oncol. 2023;149(1):467\u201381.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"12","key":"459_CR2","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1007\/s00109-022-02264-6","volume":"100","author":"L Chen","year":"2022","unstructured":"Chen L, Deng J. Role of non-coding RNA in immune microenvironment and anticancer therapy of gastric cancer. J Mol Med (Berl). 2022;100(12):1703\u201319.","journal-title":"J Mol Med (Berl)"},{"key":"459_CR3","doi-asserted-by":"crossref","unstructured":"Ashrafizaveh S, Ashrafizadeh M, Zarrabi A, Husmandi K, Zabolian A, Shahinozzaman M et al. Long non-coding RNAs in the doxorubicin resistance of cancer cells. Cancer Lett. 2021;508:104\u201314.","DOI":"10.1016\/j.canlet.2021.03.018"},{"issue":"1","key":"459_CR4","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1186\/s13046-022-02406-1","volume":"41","author":"S Mirzaei","year":"2022","unstructured":"Mirzaei S, Paskeh MDA, Okina E, Gholami MH, Hushmandi K, Hashemi M, et al. Molecular landscape of LncRNAs in prostate cancer: A focus on pathways and therapeutic targets for intervention. J Exp Clin Cancer Res. 2022;41(1):214.","journal-title":"J Exp Clin Cancer Res"},{"issue":"4","key":"459_CR5","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1159\/000490871","volume":"47","author":"LQ Li","year":"2018","unstructured":"Li LQ, Pan D, Chen Q, Zhang SW, Xie DY, Zheng XL, et al. Sensitization of gastric Cancer cells to 5-FU by MicroRNA-204 through targeting the TGFBR2-Mediated epithelial to mesenchymal transition. Cell Physiol Biochem. 2018;47(4):1533\u201345.","journal-title":"Cell Physiol Biochem"},{"key":"459_CR6","doi-asserted-by":"crossref","unstructured":"Luan M, Shi SS, Shi DB, Liu HT, Ma RR, Xu XQ et al. TIPRL, a novel tumor suppressor, suppresses cell migration, and invasion through regulating AMPK\/mTOR signaling pathway in gastric Cancer. Front Oncol. 2020; 101062.","DOI":"10.3389\/fonc.2020.01062"},{"key":"459_CR7","doi-asserted-by":"crossref","unstructured":"Teng YY, Yu HJ, Ni LY, Lu GR, Zhu YS, Zhou LL et al. IncRNA LUCAT1 acts as a potential biomarker and demonstrates malignant biological behaviors in gastric Cancer. Clin Lab. 2021; 67(8).","DOI":"10.7754\/Clin.Lab.2021.200924"},{"key":"459_CR8","doi-asserted-by":"crossref","unstructured":"Mirzaei S, Zarrabi A, Hashemi F, Zabolian A, Saleki H, Ranjbar A et al. Regulation of nuclear Factor-KappaB (NF-\u03baB) signaling pathway by non-coding RNAs in cancer: inhibiting or promoting carcinogenesis? Cancer Lett. 2021; 50963\u201380.","DOI":"10.1016\/j.canlet.2021.03.025"},{"issue":"1","key":"459_CR9","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.bbrc.2019.02.030","volume":"511","author":"S Wang","year":"2019","unstructured":"Wang S, Ni B, Zhang Z, Wang C, Wo L, Zhou C, et al. Long non-coding RNA DNM3OS promotes tumor progression and EMT in gastric cancer by associating with snail. Biochem Biophys Res Commun. 2019;511(1):57\u201362.","journal-title":"Biochem Biophys Res Commun"},{"key":"459_CR10","doi-asserted-by":"crossref","unstructured":"Kong R, Zhang EB, Yin DD, You LH, Xu TP, Chen WM et al. Long noncoding RNA PVT1 indicates a poor prognosis of gastric cancer and promotes cell proliferation through epigenetically regulating p15 and p16. Mol Cancer. 2015; 1482.","DOI":"10.1186\/s12943-015-0355-8"},{"issue":"1","key":"459_CR11","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1186\/s13046-022-02541-9","volume":"41","author":"D Li","year":"2022","unstructured":"Li D, Shen L, Zhang X, Chen Z, Huang P, Huang C, et al. LncRNA ELF3-AS1 inhibits gastric cancer by forming a negative feedback loop with SNAI2 and regulates ELF3 mRNA stability via interacting with ILF2\/ILF3 complex. J Exp Clin Cancer Res. 2022;41(1):332.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"459_CR12","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s12943-018-0874-1","volume":"17","author":"XZ Yang","year":"2018","unstructured":"Yang XZ, Cheng TT, He QJ, Lei ZY, Chi J, Tang Z, et al. LINC01133 as CeRNA inhibits gastric cancer progression by sponging miR-106a-3p to regulate APC expression and the Wnt\/\u03b2-catenin pathway. Mol Cancer. 2018;17(1):126.","journal-title":"Mol Cancer"},{"key":"459_CR13","doi-asserted-by":"crossref","unstructured":"Qiao X, Tang J, Dou L, Yang S, Sun Y, Mao H et al. Dental pulp stem Cell-Derived exosomes regulate Anti-Inflammatory and osteogenesis in periodontal ligament stem cells and promote the repair of experimental periodontitis in rats. Int J Nanomed. 2023; 184683\u2013703.","DOI":"10.2147\/IJN.S420967"},{"issue":"6","key":"459_CR14","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1080\/00365521.2024.2318363","volume":"59","author":"L Shi","year":"2024","unstructured":"Shi L, Luo B, Deng L, Zhang Q, Li Y, Sun D, et al. The LncRNA TRG-AS1 promotes the growth of colorectal cancer cells through the regulation of P2RY10\/GNA13. Scand J Gastroenterol. 2024;59(6):710\u201321.","journal-title":"Scand J Gastroenterol"},{"issue":"5","key":"459_CR15","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1007\/s13577-022-00741-1","volume":"35","author":"W Liu","year":"2022","unstructured":"Liu W, Li G, Li J, Chen W. Long noncoding RNA TRG-AS1 protects against glucocorticoid-induced osteoporosis in a rat model by regulating miR-802-mediated CAB39\/AMPK\/SIRT-1\/NF-\u03baB axis. Hum Cell. 2022;35(5):1424\u201339.","journal-title":"Hum Cell"},{"issue":"12","key":"459_CR16","doi-asserted-by":"publisher","first-page":"4135","DOI":"10.1111\/cas.15581","volume":"113","author":"D Fang","year":"2022","unstructured":"Fang D, Ou X, Sun K, Zhou X, Li Y, Shi P, et al. m6A modification-mediated LncRNA TP53TG1 inhibits gastric cancer progression by regulating CIP2A stability. Cancer Sci. 2022;113(12):4135\u201350.","journal-title":"Cancer Sci"},{"key":"459_CR17","doi-asserted-by":"crossref","unstructured":"Arriaga-Canon C, Contreras-Espinosa L, Aguilar-Villanueva S, Bargall\u00f3-Rocha E, Garc\u00eda-Gordillo JA, Cabrera-Galeana P et al. The clinical utility of LncRNAs and their application as molecular biomarkers in breast Cancer. Int J Mol Sci. 2023; 24(8).","DOI":"10.3390\/ijms24087426"},{"key":"459_CR18","doi-asserted-by":"crossref","unstructured":"Chi J, Liu T, Shi C, Luo H, Wu Z, Xiong B et al. Long non-coding RNA LUCAT1 promotes proliferation and invasion in gastric cancer by regulating miR-134-5p\/YWHAZ axis. Biomed Pharmacother. 2019; 118109201.","DOI":"10.1016\/j.biopha.2019.109201"},{"issue":"25","key":"459_CR19","doi-asserted-by":"publisher","first-page":"37812","DOI":"10.18632\/oncotarget.9336","volume":"7","author":"Y Shao","year":"2016","unstructured":"Shao Y, Ye M, Li Q, Sun W, Ye G, Zhang X, et al. LncRNA-RMRP promotes carcinogenesis by acting as a miR-206 sponge and is used as a novel biomarker for gastric cancer. Oncotarget. 2016;7(25):37812\u201324.","journal-title":"Oncotarget"},{"issue":"15","key":"459_CR20","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1080\/15384101.2020.1786622","volume":"19","author":"S He","year":"2020","unstructured":"He S, Wang X, Zhang J, Zhou F, Li L, Han X. TRG-AS1 is a potent driver of oncogenicity of tongue squamous cell carcinoma through microRNA-543\/Yes-associated protein 1 axis regulation. Cell Cycle. 2020;19(15):1969\u201382.","journal-title":"Cell Cycle"},{"issue":"8","key":"459_CR21","doi-asserted-by":"publisher","first-page":"152476","DOI":"10.1016\/j.prp.2019.152476","volume":"215","author":"H Xie","year":"2019","unstructured":"Xie H, Shi S, Chen Q, Chen Z. LncRNA TRG-AS1 promotes glioblastoma cell proliferation by competitively binding with miR-877-5p to regulate SUZ12 expression. Pathol Res Pract. 2019;215(8):152476.","journal-title":"Pathol Res Pract"},{"key":"459_CR22","doi-asserted-by":"crossref","unstructured":"Sun X, Qian Y, Wang X, Cao R, Zhang J, Chen W et al. LncRNA TRG-AS1 stimulates hepatocellular carcinoma progression by sponging miR-4500 to modulate BACH1. Cancer Cell Int. 2020; 20367.","DOI":"10.1186\/s12935-020-01440-3"},{"issue":"7","key":"459_CR23","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/j.dld.2019.11.017","volume":"52","author":"Y Tao","year":"2020","unstructured":"Tao Y, Wan X, Fan Q, Wang Y, Sun H, Ma L, et al. Long non-coding RNA OIP5-AS1 promotes the growth of gastric cancer through the miR-367-3p\/HMGA2 axis. Dig Liver Disease. 2020;52(7):773\u20139.","journal-title":"Dig Liver Disease"},{"issue":"1","key":"459_CR24","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1186\/s12967-021-03030-x","volume":"19","author":"Y Feng","year":"2021","unstructured":"Feng Y, Zhong X, Ni HF, Wang C, Tang TT, Wang LT, et al. Urinary small extracellular vesicles derived CCL21 mRNA as biomarker linked with pathogenesis for diabetic nephropathy. J Transl Med. 2021;19(1):355.","journal-title":"J Transl Med"},{"key":"459_CR25","doi-asserted-by":"crossref","unstructured":"Zhu J, Dai H, Li X, Guo L, Sun X, Zheng Z et al. LncRNA TRG-AS1 inhibits bone metastasis of breast cancer by the miR-877-5p\/WISP2 axis. Pathol Res Pract. 2023; 243154360.","DOI":"10.1016\/j.prp.2023.154360"},{"key":"459_CR26","doi-asserted-by":"crossref","unstructured":"Zhang M, Zhu W, Haeryfar M, Jiang S, Jiang X, Chen W et al. Long Non-Coding RNA TRG-AS1 promoted proliferation and invasion of lung Cancer cells through the miR-224-5p\/SMAD4 Axis. Onco Targets Ther. 2021; 144415\u201326.","DOI":"10.2147\/OTT.S297336"},{"issue":"6","key":"459_CR27","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1089\/cell.2019.0026","volume":"21","author":"L Bao","year":"2019","unstructured":"Bao L, Zhang X, Xu Y, Wang M, Song Y, Gu Y, et al. Dysfunction of MiR-148a-NRP1 functional Axis suppresses osteogenic differentiation of periodontal ligament stem cells under inflammatory microenvironment. Cell Reprogram. 2019;21(6):314\u201322.","journal-title":"Cell Reprogram"},{"key":"459_CR28","doi-asserted-by":"crossref","unstructured":"Wang Z, Liu W, Wang C, Ai Z. miR-873-5p inhibits cell migration and invasion of papillary thyroid Cancer via regulation of CXCL16. Onco Targets Ther. 2020; 131037\u201346.","DOI":"10.2147\/OTT.S213168"},{"issue":"12","key":"459_CR29","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1111\/jgh.14697","volume":"34","author":"Y Zhu","year":"2019","unstructured":"Zhu Y, Zhang X, Qi M, Zhang Y, Ding F. miR-873-5p inhibits the progression of colon cancer via repression of tumor suppressor candidate 3\/AKT signaling. J Gastroenterol Hepatol. 2019;34(12):2126\u201334.","journal-title":"J Gastroenterol Hepatol"},{"issue":"5","key":"459_CR30","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.21037\/jgo-21-641","volume":"12","author":"Q Chen","year":"2021","unstructured":"Chen Q, Lin L, Xiong B, Yang W, Huang J, Shi H, et al. MiR-873-5p targets THUMPD1 to inhibit gastric cancer cell behavior and chemoresistance. J Gastrointest Oncol. 2021;12(5):2061\u201372.","journal-title":"J Gastrointest Oncol"}],"container-title":["Hereditas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41065-025-00459-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41065-025-00459-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41065-025-00459-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T04:02:13Z","timestamp":1748491333000},"score":1,"resource":{"primary":{"URL":"https:\/\/hereditasjournal.biomedcentral.com\/articles\/10.1186\/s41065-025-00459-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,29]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["459"],"URL":"https:\/\/doi.org\/10.1186\/s41065-025-00459-8","relation":{},"ISSN":["1601-5223"],"issn-type":[{"value":"1601-5223","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,29]]},"assertion":[{"value":"20 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. The Ethics Committee of Henan Provincial People\u2019s Hospital gave its approval for the collecting of all samples, and the subjects voluntarily and signed the informed consent for this trial.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"88"}}